Table 1 Univariable and multivariable conditional logistic regression models comparing patients developing metastatic disease with patients free from disseminating disease in a nested case–control study
Variablea | n | Univariate models | Multivariate models | ||||
|---|---|---|---|---|---|---|---|
HRb | 95% CI | P | HRb | 95% CI | P | ||
vCAF metagene | 1.47 | 1.23–1.76 | <0.001 | 1.66 | 1.33–2.08 | <0.001 | |
mCAF metagene | 1.28 | 1.07–1.53 | 0.005 | 1.32 | 1.05–1.66 | 0.015 | |
Lymph node status | <0.001 | 0.003 | |||||
Negative | 304 | 1 (ref.) | 1 (ref.) | ||||
Positive | 442 | 2.52 | 1.69–3.77 | 2.06 | 1.34–3.16 | ||
Unknown | 22 | 1.11 | 0.36–3.41 | 1.84 | 0.52–6.46 | ||
Tumor size, mm | 0.007 | 0.010 | |||||
≤20 | 354 | 1 (ref.) | 1 (ref.) | ||||
>20 | 398 | 1.73 | 1.22–2.44 | 1.81 | 1.21–2.71 | ||
Unknown | 16 | 0.98 | 0.27–3.59 | 0.78 | 0.19–3.29 | ||
Histologic grade | <0.001 | 0.012 | |||||
Grade 1 | 68 | 1 (ref.) | 1 (ref.) | ||||
Grade 2 | 327 | 4.86 | 1.91–12.39 | 3.76 | 1.38–10.20 | ||
Grade 3 | 328 | 3.94 | 1.52–10.23 | 2.51 | 0.87– 7.20 | ||
Unknown | 45 | 3.46 | 1.09–10.98 | 3.07 | 0.84–11.20 | ||
HER2 status | <0.001 | 0.001 | |||||
Negative | 519 | 1 (ref.) | 1 (ref.) | ||||
Positive | 145 | 2.60 | 1.74–3.88 | 2.24 | 1.44–3.49 | ||
Unknown | 104 | 0.75 | 0.44–1.31 | 0.98 | 0.50–1.92 | ||
Proliferation metagenec | 1.20 | 0.99–1.46 | 0.061 | 1.77 | 1.31–2.40 | <0.001 | |